Actos Settlement Fund Announced

Urgent Product Information Bulletin:

Takeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims resulting from Actos use. The settlement was designed to compensate claimants based upon the extent of their injuries and their cumulative exposure to Actos, taking into account risk factors that may have caused or contributed to the diagnosis of bladder cancer.

To be eligible to participate, a claimant must have taken Actos prior to December 1, 2011, been diagnosed with bladder cancer, and either have a suit pending or have signed an attorney contract no later than noon Eastern Standard Time May 1, 2015. If eligible and in order to participate in the $2.4 billion settlement fund, please contact Sherrod & Bernard, P.C., before Friday, May 1, 2015.

Author: Ken Bernard

Kenneth R. Bernard Jr. serves as the Managing Partner of Sherrod & Bernard, P.C. A native of Douglas County, Kenneth earned both his undergraduate and law degrees from the University of Georgia. He then served his country as a Judge Advocate General in the U.S. Marine Corps, attaining the rank of Captain during Operation Desert Shield and Operation Desert Storm. After his service, Ken returned home and joined forces with John Sherrod to launch Sherrod & Bernard, P.C., a law firm with a mission of providing superior legal services with a neighborly touch. In addition to his practice, Ken has served on several boards and committees, including three terms as Chairman of the University System of Georgia Foundation, Inc.